Help - Search - Members - Calendar
Full Version: Arthritis
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Internal Medicine Forum > Medicine Topics > Arthritis
Pages: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
  1. Arthritis: Factors causing cartilage, bone destruction in arthritis suppressed by green tea compound (0 replies)
  2. Arthritis: Green tea compound may be a therapy for rheumatoid arthritis (0 replies)
  3. Arthritis: Psoriatic arthritis symptoms and causes (0 replies)
  4. Arthritis: Genes could boost arthritis patients' death risk (0 replies)
  5. Arthritis: Genes could boost arthritis patients' death risk (0 replies)
  6. Arthritis: As boomers age, arthritis costs rise (0 replies)
  7. Arthritis: As boomers age, arthritis costs rise (0 replies)
  8. Arthritis: Green tea may ease rheumatoid arthritis (0 replies)
  9. Arthritis: Costs of treating arthritis on the rise nationwide, study finds (0 replies)
  10. Arthritis: Brief report - glucocorticoid receptor gene polymorphisms and susceptibility to rheumatoid arthritis. (0 replies)
  11. Arthritis: Green tea ingredient may curb destruction of rheumatoid arthritis (0 replies)
  12. Arthritis: Indirect immunofluorescent assay for antinuclear antibodies on mccoy-plovdiv serum-free cell line substrate. (0 replies)
  13. Arthritis: Computer-aided joint space analysis (cajsa) of the proximal-interphalangeal joint-normative age-related and gender specific data. (0 replies)
  14. Arthritis: Unnecessary scare about common painkillers caused by fda (0 replies)
  15. Arthritis: Fda approves labeling update for orencia® (abatacept) to inhibit structural joint damage in adults with moderate to severe rheumatoid arthritis (0 replies)
  16. Arthritis: Fda approves labeling update for orencia® (abatacept) to inhibit structural joint damage in adults with moderate to severe rheumatoid arthritis (0 replies)
  17. Arthritis: Exemestane: first report of rheumatoid arthritis: case report. (0 replies)
  18. Arthritis: Failure to confirm association between
    pdcd1
    polymorphisms and rheumatoid arthritis in a japanese population     (0 replies)
  19. Arthritis: Bone loss in patients with psoriatic arthritis and psoriasis vulgaris (0 replies)
  20. Arthritis: Prevalence and predictors of ocular manifestations of ra: is there a need for routine screening? (0 replies)
  21. Arthritis: Fda rejects merck's vioxx successor (0 replies)
  22. Arthritis: Fda rejects merck's vioxx successor (0 replies)
  23. Arthritis: Fda rejects merck's vioxx successor (0 replies)
  24. Arthritis: Costs of arthritis grow with population (0 replies)
  25. Arthritis: Fda rejects merck's presumed vioxx successor (0 replies)
  26. Arthritis: Fda rejects merck's vioxx successor (0 replies)
  27. Arthritis: Aging americans crank up nation's arthritis financial burden (0 replies)
  28. Arthritis: Fda rejects merck's vioxx successor
    (ap)     (0 replies)
  29. Arthritis: Fda rejects merck's proposed successor to vioxx (0 replies)
  30. Arthritis: Spending on arthritis hits $322 billion (0 replies)
  31. Arthritis: Fever (0 replies)
  32. Arthritis: Health tip: removing a tick (0 replies)
  33. Arthritis: Fda does not approve arthritis painkiller (0 replies)
  34. Arthritis: U.s. arthritis numbers, costs soaring (0 replies)
  35. Arthritis: Genes could boost arthritis patients' death risk (0 replies)
  36. Arthritis: Costs of treating arthritis on the rise nationwide, study finds (0 replies)
  37. Arthritis: The economic impact of arthritis on the united states (0 replies)
  38. Arthritis: Health tip: dealing with osteoarthritis (0 replies)
  39. Arthritis: Soluble fas ligand inhibits angiogenesis in rheumatoid arthritis (0 replies)
  40. Arthritis: Arthritis survey launched in canada (0 replies)
  41. Arthritis: Spending on biotech drug prescriptions rising (0 replies)
  42. Arthritis: Rheumatoid arthritis – phenomenological concepts (0 replies)
  43. Arthritis: The prevalence and diagnostic significance of accp antibodies and rheumatoid factor in rheumatoid arthritis patients (0 replies)
  44. Arthritis: Felty’s syndrome and t-cell large granular lymphocyte leukaemia – similarities and differences (0 replies)
  45. Arthritis: Civilian extraperitoneal rectal gunshot wounds: surgical management made simpler (0 replies)
  46. Arthritis: Rheumatoid arthritis - my doctor says i need remicade (0 replies)
  47. Arthritis: Cheaper, better disease treatments expected from faster approach to developing antibodies (0 replies)
  48. Arthritis: Arthritis causes and symptoms (0 replies)
  49. Arthritis: Arthritis causes and symptoms (0 replies)
  50. Arthritis: Alabama law firm sues makers of celebrex (0 replies)
  51. Arthritis: Our picks of the week's stories from the national electronic library for medicines news service, apr 16 - 20 (0 replies)
  52. Arthritis: Health tip: can you recognize osteoarthritis symptoms? (0 replies)
  53. Arthritis: Autoantibodies help t cells "see" their target (0 replies)
  54. Arthritis: Autoantibodies help t cells "see" their target (0 replies)
  55. Arthritis: Autoantibodies help t cells 'see' their target (0 replies)
  56. Arthritis: Tnf-alpha blockers increase risk of serious infection in patients with rheumatoid arthritis? (0 replies)
  57. Arthritis: Fda advisers give overwhelming rejection to etoricoxib (arcoxia) (0 replies)
  58. Arthritis: New type of drug helpful in type 2 diabetes (0 replies)
  59. Arthritis: Fda advisory panel votes "no" to etoricoxib (0 replies)
  60. Arthritis: Rheumatoid arthritis drug may help treat type 2 diabetes (0 replies)
  61. Arthritis: Rheumatoid arthritis drug may help treat type 2 diabetes (0 replies)
  62. Arthritis: Development of acute inflammatory arthritis by granulocyte-macrophage colony-stimulating factor during autologous stem cell transplantation for cryoglobulinemia (0 replies)
  63. Arthritis: Predicting factors for severity of rheumatoid arthritis: a prospective multicenter cohort study of 172 patients over 3 years (0 replies)
  64. Arthritis: Eight versus 16-week re-evaluation period in rheumatoid arthritis patients treated with leflunomide or methotrexate accompanied by moderate dose prednisone (0 replies)
  65. Arthritis: Vitiligo gene linked to other autoimmune diseases (0 replies)
  66. Arthritis: Genes gang up to help cancer spread, study finds (0 replies)
  67. Arthritis: Rigel provides clinical update of r788 phase 2 trials in itp, rheumatoid arthritis and lymphoma (0 replies)
  68. Arthritis: Healthsonix, inc.: healthsonix to conduct joint clinical studies with major drug manufacturers (0 replies)
  69. Arthritis: Upper-airway obstruction after short posterior occipitocervical fusion in a flexed position. (0 replies)
  70. Arthritis: Slick and springy: brown research reveals protein's role in joints (0 replies)
  71. Arthritis: Total hip replacement (0 replies)
  72. Arthritis: Ibuprofen puts high risk cardiac patients at risk--drug interaction may cause heart attacks (0 replies)
  73. Arthritis: Serum pro-matrix metalloproteinase-3 as an indicator of disease activity and severity in rheumatoid arthritis: comparison with traditional markers (0 replies)
  74. Arthritis: The receptor for advanced glycation end products glycine 82 serine polymorphism and the risk of cardiovascular events in rheumatoid arthritis (0 replies)
  75. Arthritis: Rheumatoid arthritis drug may help treat type 2 diabetes (0 replies)
  76. Arthritis: Quantitative structure-activity relationship of peptides binding to the class ii major histocompatibility complex molecule aq associated with autoimmune arthritis (0 replies)
  77. Arthritis: Fusion expression of ddr2 extracellular domain in insect cells and its purification and function characterization (0 replies)
  78. Arthritis: Work disability associated with cancer survivorship and other chronic conditions (0 replies)
  79. Arthritis: Initiating anti-tnf therapy in a patient with ra (0 replies)
  80. Arthritis: A new classification of hla-drb1 alleles differentiates predisposing and protective alleles for autoantibody production in rheumatoid arthritis (0 replies)
  81. Arthritis: Scientists implicate gene in vitiligo and other autoimmune diseases - april 10, 2007 (0 replies)
  82. Arthritis: A wonder drug beat my teenage arthritis (0 replies)
  83. Arthritis: Colonization and impact of disease and other factors on intestinal microbiota (0 replies)
  84. Arthritis: Vaccination response to tetanus toxoid and 23-valent pneumococcal vaccines following administration of a single dose of abatacept: a randomized, open-label, parallel group study in healthy subjects (0 replies)
  85. Arthritis: Prednisolone/paroxetine [crx 139] * may be effective in rheumatoid arthritis. (0 replies)
  86. Arthritis: Doctors: arthritis drug arcoxia risky too (0 replies)
  87. Arthritis: Nice issues consultation document for adalimumab for moderate to severe psoriatic arthritis (0 replies)
  88. Arthritis: Statement by merck & co., inc. regarding fda arthritis drugs advisory committee meeting on arcoxia® (etoricoxib) (0 replies)
  89. Arthritis: The association between patella alignment on mri and radiographic manifestations of knee osteoarthritis (0 replies)
  90. Arthritis: Angiotensin ii type 1 receptor antagonists such as losartan may have potential in the treatment of rheumatoid arthritis (0 replies)
  91. Arthritis: Adalimumab effective against psoriatic arthritis long-term (0 replies)
  92. Arthritis: Corticosteroids: cellulitis and infectious arthritis associated with mycobacterial infections following intra-articular administration: case report (0 replies)
  93. Arthritis: Slick and springy: brown research reveals protein's role in joints (0 replies)
  94. Arthritis: Prevalence and correlates of arthritis-attributable work limitation in the us population among persons ages 18-64: 2002 national health interview survey data (0 replies)
  95. Arthritis: Comment on "aberrant regulation of synovial t cell activation by soluble costimulatory molecules in rheumatoid arthritis". (0 replies)
  96. Arthritis: Arthritis makes work tough going for millions (0 replies)
  97. Arthritis: Heart patients face risks from ibuprofen (0 replies)
  98. Arthritis: Risk factors for pes anserinus tendinitis/bursitis syndrome: a case control study. (0 replies)
  99. Arthritis: Rheumatoid arthritis patients' experiences of night pain. (0 replies)
  100. Arthritis: Risk factors associated with the cumulative survival of low-dose methotrexate in 273 japanese patients with rheumatoid arthritis. (0 replies)
  101. Arthritis: Successful etanercept use in an hiv-positive patient with rheumatoid arthritis. (0 replies)
  102. Arthritis: Successful rituximab therapy of acquired factor viii inhibitor in a patient with rheumatoid arthritis. (0 replies)
  103. Arthritis: Basic science for the clinician 43: the mitogen-activated protein kinase family in inflammatory signaling. (0 replies)
  104. Arthritis: The construction of standard gamble utilities (0 replies)
  105. Arthritis: [mechanisms of signal transduction] basic fibroblast growth factor stimulates matrix metalloproteinase-13 via the molecular cross-talk between the mitogen-activated protein kinases and protein kinase c{delta} pathways in human adult articu (0 replies)
  106. Arthritis: Heart experts say merck arthritis drug too risky (0 replies)
  107. Arthritis: April 5, 2007: in the news (0 replies)
  108. Arthritis: Arthritis pain killer danger (0 replies)
  109. Arthritis: Seronegative lyme arthritis (0 replies)
  110. Arthritis: Depression history, stress, and pain in rheumatoid arthritis patients (0 replies)
  111. Arthritis: Total knee replacement (0 replies)
  112. Arthritis: A pilot study of il-1 inhibition by anakinra in acute gout (0 replies)
  113. Arthritis: Physical activity associated with lower risk of work-related repetitive strain injury (0 replies)
  114. Arthritis: Physical activity associated with lower risk of work-related repetitive strain injury (0 replies)
  115. Arthritis: Painkiller fear for 50-plus arthritics (0 replies)
  116. Arthritis: Exercise may fend off arthritis in women
    (ap)     (0 replies)
  117. Arthritis: Exercise may fend off arthritis in women (0 replies)
  118. Arthritis: Exercise may fend off arthritis in women (0 replies)
  119. Arthritis: Elevated triglyceride and cholesterol levels after intravenous antitumour necrosis factor-α therapy in a patient with psoriatic arthritis and psoriasis vulgaris (0 replies)
  120. Arthritis: Juvenile psoriatic arthritis carrying familial mediterranean fever gene mutations in a 14-year-old turkish girl (0 replies)
  121. Arthritis: A newly identified immunosuppressive protein in rheumatoid arthritis (0 replies)
  122. Arthritis: A newly identified immunosuppressive protein in rheumatoid arthritis (0 replies)
  123. Arthritis: Exercise may fight off arthritis in women (0 replies)
  124. Arthritis: Arthritis pain, the brain and the role of emotions (0 replies)
  125. Arthritis: Arthritis pain, the brain and the role of emotions (0 replies)
  126. Arthritis: Is the toxicity of sulfasalazine when used in ulcerative colitis the same as when used for rheumatoid arthritis, and are the monitoring requirements the same? (0 replies)
  127. Arthritis: Ibuprofen may boost aspirin users' heart risk (0 replies)
  128. Arthritis: Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumour necrosis factor alpha gene promoter (0 replies)
  129. Arthritis: The aryl propionic acid r-flurbiprofen selectively induces p75ntr-dependent decreased survival of prostate tumor cells (0 replies)
  130. Arthritis: Exercise may fend off arthritis in women (0 replies)
  131. Arthritis: Exercise may fend off arthritis in women (0 replies)
  132. Arthritis: Exercise may fend off arthritis in women
    (ap)     (0 replies)
  133. Arthritis: Exercise may fend off arthritis in women (0 replies)
  134. Arthritis: Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis. (0 replies)
  135. Arthritis: Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis. (0 replies)
  136. Arthritis: Supercomputer simulations may pinpoint causes of parkinson's, alzheimer's diseases (0 replies)
  137. Arthritis: Hla-c locus alleles may modulate the clinical expression of psoriatic arthritis (0 replies)
  138. Arthritis: [mechanisms of signal transduction] critical role for polar residues in coupling leukotriene b4 binding to signal transduction in blt1 (0 replies)
  139. Arthritis: Low molecular weight proteins of outer membrane of salmonella typhimurium are immunogenic in salmonella induced reactive arthritis revealed by proteomics (0 replies)
  140. Arthritis: Juvenile arthritis (juvenile rheumatoid arthritis) (0 replies)
  141. Arthritis: Diffuse alveolar hemorrhage in colombian patients with systemic lupus erythematosus (0 replies)
  142. Arthritis: Rheumatoid arthritis and effusions (0 replies)
  143. Arthritis: Alt.med.fibromyalgia | google groups (0 replies)
  144. Arthritis: Special master refuses to take judicial notice of omnibus findings (0 replies)
  145. Arthritis: Combination therapy may be more effective than single-dose therapy for ra (0 replies)
  146. Arthritis: Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (ip)-10/cxcl10 levels and increased number of ccr5+ and cxcr3+ cd4 t cells in synovial fluid of patients with enthesitis-related arthritis (era) (0 replies)
  147. Arthritis: Joint aspiration (arthrocentesis) (0 replies)
  148. Arthritis: Risk:benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis (0 replies)
  149. Arthritis: Impact of cytokines and t lymphocytes upon osteoclast differentiation and function (0 replies)
  150. Arthritis: Timing of cervical spine stabilisation and outcome in patients with rheumatoid arthritis (0 replies)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2009 Invision Power Services, Inc.